Search Results - "Sanz, Gines"

Refine Results
  1. 1
  2. 2
  3. 3

    Evolution of the Polypill Concept and Ongoing Clinical Trials by Castellano, Jose M., MD, PhD, Sanz, Gines, MD, PhD, Fuster, Valentin, MD, PhD

    Published in Canadian journal of cardiology (01-05-2014)
    “…Abstract Ischemic heart disease and stroke are the leading causes of death worldwide. What was once thought to be an endemic disease of high income countries…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevention: Polypills for cardiovascular prevention: a step forward? by Sanz, Ginés, Fuster, Valentin

    Published in Nature reviews cardiology (01-12-2013)
    “…The effect of a fixed-dose combination drug strategy ('polypill') on patients' adherence to medication was analysed in a series of 2,004 individuals with, or…”
    Get full text
    Journal Article
  6. 6

    A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention: From Concept to Reality by CASTELLANO, José M, SANZ, Ginés, ORTIZ, Antonio Fernandez, GARRIDO, Ester, BANSILAL, Sameer, FUSTER, Valentin

    “…The prevention of cardiovascular disease (CVD) by using a polypill has gained increasing momentum as a strategy to contain progression of the disease. Since…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Polypills for cardiovascular prevention: a step forward? by Sanz, Ginés, Fuster, Valentin

    Published in Nature reviews cardiology (01-12-2013)
    “…The effect of a fixed-dose combination drug strategy ('polypill') on patients' adherence to medication was analysed in a series of 2,004 individuals with, or…”
    Get full text
    Journal Article
  11. 11

    Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK by Becerra, Virginia, Gracia, Alfredo, Desai, Kamal, Abogunrin, Seye, Brand, Sarah, Chapman, Ruth, García Alonso, Fernando, Fuster, Valentín, Sanz, Ginés

    Published in BMJ open (01-01-2015)
    “…Objective To evaluate the public health and economic benefits of adherence to a fixed-dose combination polypill for the secondary prevention of cardiovascular…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long‐term, followup study by Perez‐Villa, Felix, Font, Josep, Azqueta, Manel, Espinosa, Gerard, Pare, Carles, Cervera, Ricard, Reverter, Joan C., Ingelmo, Miguel, Sanz, Gines

    Published in Arthritis and rheumatism (15-06-2005)
    “…Objective To assess whether the presence of antiphospholipid antibodies is related to the incidence and progression of severe valvular dysfunction and the need…”
    Get full text
    Journal Article
  14. 14

    Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population by Sanz, Ginés, Fuster, Valentin

    “…Secondary prevention of ischemic heart disease could have a huge impact on the global epidemic of cardiovascular disease. Here Ginés Sanz and Valentin Fuster…”
    Get full text
    Journal Article
  15. 15

    Myocardial involvement in Chagas disease: Insights from cardiac magnetic resonance by Regueiro, Ander, García-Álvarez, Ana, Sitges, Marta, Ortiz-Pérez, José Tomás, De Caralt, Maria Teresa, Pinazo, María Jesús, Posada, Elizabeth, Heras, Magda, Gascón, Joaquim, Sanz, Ginés

    Published in International journal of cardiology (30-04-2013)
    “…Abstract Background Chagas' disease is becoming a public health problem in Europe because of migratory movements. Cardiac magnetic resonance (CMR) has emerged…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Aragon workers' health study--design and cohort description by Casasnovas, José A, Alcaide, Victor, Civeira, Fernando, Guallar, Eliseo, Ibañez, Borja, Borreguero, Jesús Jiménez, Laclaustra, Martin, León, Montserrat, Peñalvo, José Luis, Ordovás, José M, Pocovi, Miguel, Sanz, Ginés, Fuster, Valentín

    Published in BMC cardiovascular disorders (19-06-2012)
    “…Spain, a Mediterranean country with relatively low rates of coronary heart disease, has a high prevalence of traditional cardiovascular risk factors and is…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Polypill and Global Cardiovascular Health Strategies by Sanz, Ginés, MD, PhD, Fuster, Valentin, MD, PhD

    “…Despite encouraging advances in our knowledge of the prevention and treatment of atherothrombosis, cardiovascular (CV) disease remains the leading cause of…”
    Get full text
    Journal Article